Literature DB >> 20624407

Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors.

Cedric Mombereau1, Yukio Kawahara, Brigitta B Gundersen, Kazuko Nishikura, Julie A Blendy.   

Abstract

Serotonin 2C receptors (5-HT(2C)R) have been shown to undergo post-transcriptional RNA editing. This modification affects the affinity, coupling and constitutive activity of the receptor. In vivo, manipulations such as stress or antidepressant administration dramatically modify the pattern of 5-HT(2C)R mRNA editing, suggesting that this phenomenon might be involved in the pathophysiology of stress-related disorders. Indeed, alterations of 5-HT(2C)R mRNA editing have been observed in depressed patients. Thus, the recent development of mice expressing either the non-edited (5-HT(2C)R-INI) or the fully-edited form of 5-HT(2C)R (5-HT(2C)R-VGV) provides a novel opportunity to investigate the relevance of this phenomenon in the context of stress-related disorders. We observed that both 5-HT(2C)R-INI and 5-HT(2C)R-VGV mice exhibit exaggerated anxiety-like behaviors in the elevated-plus maze paradigm. This phenotype was observed when the INI or VGV mutations were present in mice on a BALB/c background, as well as non-significant trends in the same direction in mice on a C57BL/6J background. In animal models of antidepressant-like activity, the absence of editing of 5-HT(2C)R mRNA (5-HT(2C)R-INI) induced an increase in the time spent immobile in the forced-swim test (FST) and tail suspension test (TST). Complete editing of 5-HT(2C) receptor mRNA (5-HT(2C)R-VGV) induced antidepressant-like behavior in the FST and TST, as reflected by a significant decrease in time spent immobile. These phenotypes were unrelated to alterations in locomotor activity in both 5-HT(2C)R-INI and 5-HT(2C)R-VGV. In the TST, these phenotypes were accompanied by a decrease and an increase in response to desipramine in 5-HT(2C)R-INI and 5-HT(2C)R-VGV, respectively. These data constitute the first in vivo demonstration of a role for 5-HT(2C)R mRNA editing in anxiety- and depression-related behaviors.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624407      PMCID: PMC2946438          DOI: 10.1016/j.neuropharm.2010.06.009

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  27 in total

1.  RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.

Authors:  C M Niswender; K Herrick-Davis; G E Dilley; H Y Meltzer; J C Overholser; C A Stockmeier; R B Emeson; E Sanders-Bush
Journal:  Neuropsychopharmacology       Date:  2001-05       Impact factor: 7.853

2.  Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice.

Authors:  E M Lepicard; C Joubert; I Hagneau; F Perez-Diaz; G Chapouthier
Journal:  Pharmacol Biochem Behav       Date:  2000-12       Impact factor: 3.533

3.  RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms.

Authors:  Sébastien Marion; David M Weiner; Marc G Caron
Journal:  J Biol Chem       Date:  2003-11-05       Impact factor: 5.157

4.  Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims.

Authors:  Ilona Gurevich; Hadassah Tamir; Victoria Arango; Andrew J Dwork; J John Mann; Claudia Schmauss
Journal:  Neuron       Date:  2002-04-25       Impact factor: 17.173

5.  dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing.

Authors:  M J Palladino; L P Keegan; M A O'Connell; R A Reenan
Journal:  RNA       Date:  2000-07       Impact factor: 4.942

6.  Compulsive behavior in the 5-HT2C receptor knockout mouse.

Authors:  Jennifer M Chou-Green; Todd D Holscher; Mary F Dallman; Susan F Akana
Journal:  Physiol Behav       Date:  2003-04

7.  Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade.

Authors:  Thomas I F H Cremers; Marco Giorgetti; Fokko J Bosker; Sandra Hogg; Jørn Arnt; Arne Mørk; Gerard Honig; Klaus-Peter Bøgesø; Ben H C Westerink; Hans den Boer; Håkan V Wikstrom; Laurence H Tecott
Journal:  Neuropsychopharmacology       Date:  2004-10       Impact factor: 7.853

8.  Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy.

Authors:  Weidong Yang; Qingde Wang; Stephen J Kanes; John M Murray; Kazuko Nishikura
Journal:  Brain Res Mol Brain Res       Date:  2004-04-29

9.  Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2.

Authors:  Minati Singh; M Bridget Zimmerman; Terry G Beltz; Alan Kim Johnson
Journal:  Physiol Behav       Date:  2009-04-08

10.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

View more
  19 in total

1.  New horizons for selective 5-HT2C receptor ligands in psychiatric/neurological disorders.

Authors:  Sharon Rosenzweig-Lipson
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

2.  Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents.

Authors:  Jianjun Cheng; Patrick M Giguère; Oluseye K Onajole; Wei Lv; Arsen Gaisin; Hendra Gunosewoyo; Claire M Schmerberg; Vladimir M Pogorelov; Ramona M Rodriguiz; Giulio Vistoli; William C Wetsel; Bryan L Roth; Alan P Kozikowski
Journal:  J Med Chem       Date:  2015-02-10       Impact factor: 7.446

3.  Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia.

Authors:  Baoman Li; Lu Dong; Bing Wang; Liping Cai; Ning Jiang; Liang Peng
Journal:  Neurochem Res       Date:  2012-06-19       Impact factor: 3.996

Review 4.  50 years of hurdles and hope in anxiolytic drug discovery.

Authors:  Guy Griebel; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2013-09       Impact factor: 84.694

Review 5.  A-to-I editing of coding and non-coding RNAs by ADARs.

Authors:  Kazuko Nishikura
Journal:  Nat Rev Mol Cell Biol       Date:  2015-12-09       Impact factor: 94.444

6.  Enhancement of alcohol drinking in mice depends on alterations in RNA editing of serotonin 2C receptors.

Authors:  Yoshihisa Watanabe; Kanji Yoshimoto; Harutsugu Tatebe; Masakazu Kita; Kazuko Nishikura; Minoru Kimura; Masaki Tanaka
Journal:  Int J Neuropsychopharmacol       Date:  2013-12-17       Impact factor: 5.176

7.  Transcript diversification in the nervous system: a to I RNA editing in CNS function and disease development.

Authors:  Aamira Tariq; Michael F Jantsch
Journal:  Front Neurosci       Date:  2012-07-09       Impact factor: 4.677

8.  Prevention of 5-hydroxytryptamine2C receptor RNA editing and alternate splicing in C57BL/6 mice activates the hypothalamic-pituitary-adrenal axis and alters mood.

Authors:  Vincent Bombail; Wei Qing; Karen E Chapman; Megan C Holmes
Journal:  Eur J Neurosci       Date:  2014-09-26       Impact factor: 3.386

9.  Comparative RNA editing in autistic and neurotypical cerebella.

Authors:  A Eran; J B Li; K Vatalaro; J McCarthy; F Rahimov; C Collins; K Markianos; D M Margulies; E N Brown; S E Calvo; I S Kohane; L M Kunkel
Journal:  Mol Psychiatry       Date:  2012-08-07       Impact factor: 15.992

Review 10.  The vital role of constitutive GPCR activity in the mesolimbic dopamine system.

Authors:  F J Meye; G M J Ramakers; R A H Adan
Journal:  Transl Psychiatry       Date:  2014-02-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.